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Objective: To high light some epidemiological, clinical and diagnostic features of
dengue fever during an outbreak and the role of different diagnostic techniques to achieve
the highest level of accuracy in results.
Methods: Blood samples (n = 323) were collected along with epidemiological and
clinical data from suspected dengue patients who visited different hospitals in Swat and
Mansehra district of Pakistan between May–November 2013 during a dengue outbreak.
Samples were tested for the detection of viral nucleic acid by real-time PCR, non
structural protein-1 (NS1) antigen and IgM antibodies by ELISA.
Results: Out of 323 cases with clinical dengue infection, 304 were positive by one or
more diagnostic parameter; 201 samples were positive by real-time PCR, 209 were
positive by NS1 ELISA and 190 were positive by IgM antibodies. Sensitivities of real-
time PCR and NS1 ELISA were comparable for early diagnosis of dengue virus infec-
tion, IgM antibody detection assay was found useful for the diagnosis in the samples
collected later than day 5 of onset.
Conclusions: The use of real-time PCR or detection of non structural protein NS1 by
ELISA followed by IgM antibodies detection can be recommended for early diagnosis of
dengue virus infection with a high level of accuracy.1. Introduction
Dengue fever is an important emerging and re-emerging
arboviral infection and major public health problem of tropical
and subtropical regions of the world [1,2]. According to the
World Health Organization 2.5 billion people and 124
countries are at risk of dengue infection with over 100 million
cases of dengue virus (DENV) infection and 30000 estimated
deaths. In most of the dengue endemic countries the DENV
has caused regular cyclic epidemics after every 3–5 years [3].
Dengue fever is caused by the DENV which belongs to the
genus Flavivirus, family ﬂaviviridae and has been classiﬁed into
four (DENV-1-4) serotypes and ten genotypes on the basis ofnucleotides differences in the sequence of envelope gene [4,5].
The DENV infection is classiﬁed into three categories ranging
from mild dengue fever to severe life threatening dengue
hemorrhagic fever (DHF) and dengue shock syndrome (DSS)
[6]. There are 500000 cases of DHF and DSS reported
annually which are related to severe disease manifestation
characteristic of secondary infection [7,8].
Pakistan has a temperate climate and the DENV has been
endemic for many years [9–12]. However, since 2006 dengue
outbreaks have been reported every year and co-circulation of
multiple dengue serotypes has been reported [9]. The presence of
rich fauna, vast agricultural land, open irrigation channels,
artiﬁcial water reservoirs for power generation and ﬂoods from
heavy rainfall provide ample breeding sites for the mosquito
vector(s). The DENV vector activities differ according to
season in different geographical areas of Pakistan and
typically the incidence of cases increases after the rainy
season [7].rticle under the CC BY-NC-ND license (http://
Table 1
Epidemiological characteristics of patients enrolled in the study
(n = 323).
Clinical and demographic
features
Dengue
positive
Dengue
negative
P-
value
Number of patients [n (%)] 304 (94) 19 (6) –
Mean age (years) (mean ± SD) 29.35 ± 19.44 34.11 ± 15.32 0.025
Male [n (%)] 198 (61) 14 (7) 0.006
Female [n (%)] 106 (33) 5 (5)
Days after illness onset
(mean ± SD)
4.78 ± 2.06 6.35 ± 3.48 0.001
Platelets counts (cell/mL) 4344 2418 0.001
TLC count (cell/mL) 137 948 0.001
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diagnosis of DENV infection, like virus isolation, conventional
reverse transcriptase polymerase chain reaction (RT-PCR), real-
time PCR, genomic sequencing, ELISA for detection of viral
antigen and IgM, IgG antibodies [13]. Virus isolation and
molecular techniques are highly sensitive assays but often
need a specialized laboratory setting and highly trained staff as
well. In a developing country like Pakistan, serology is the
more commonly used method for diagnosis of dengue
infections. Although RT-PCR and viral antigen non structural
protein-1 (NS1) detection by ELISA are highly sensitive tech-
niques for the early diagnosis of DENV, they are not routinely
used in public health laboratories due to resource limitations.
The aim of the present study was to evaluate the diagnostic
accuracy of different diagnostic tests such as NS1 ELISA, real-
time PCR and IgM ELISA for the detection of DENV infection
during an outbreak and correlate with clinical data especially the
date of onset of infection.
2. Materials and methods
A total of 323 blood specimens collected from the suspected
DENV cases were transported to the Department of Virology
National Institute of Health Islamabad maintaining cold chain.
This study was approved by the Internal Review Board of Na-
tional Institute of Health, Islamabad, Pakistan.
Sera were separated by centrifuging the whole blood at
3000 rpm for 10 min. Each sample was analyzed for the
detection of NS1 antigen and IgM antibodies by ELISA and
viral RNA by real-time PCR. All serum samples were stored
at −80 C until further use.
2.1. Detection of NS1 antigen
NS1 antigen was detected by using Platelia dengue antigen
detection kit (Biorad Laboratories, Marnes-la-Coquette, France)
according to the instruction provided by the manufacturer.
Brieﬂy, sample diluents buffer (50 mL) was added to each well
of microplate followed by the addition of serum, positive and
negative controls (50 mL) and conjugate (100 mL). After the
addition of conjugate, microwell plate was covered with an
adhesive plate sealer and incubation at 37 C for 90 min. After
incubation, plate was washed and 160 mL of substrate was added
followed by incubated at room temperature for 30 min. The
presence of NS1 antigen was demonstrated by a color devel-
opment and reading of optical density (OD) at a wavelength of
450 nm. Test results were determined by comparing the OD
values of sample to the OD values of cut-off controls.
2.2. Viral RNA detection by real-time PCR
RNA was extracted using 140 mL of serum samples with
QIAamp Viral RNA Mini Kit (Qiagen, Germany) according to
the protocol provided by manufacturer.
Serotype speciﬁc four-plex, real-time TaqMan RT-PCR was
carried out according to the CDC protocol developed by John-
son et al [14]. Brieﬂy, four-plex reaction mixtures of 25 mL were
run for each DENV serotype (DENV-1-4) in ABI7500 real-time
thermocycler using the SuperScript Ⅲ Platinum one-step qRT-
PCR kit (Invitrogen). Ampliﬁcations for each serotype was
carried out separately in 25 mL reaction mixture containing 5 mLextracted RNA, 12.5 mL of 2 × reaction mixture, 0.5 mL enzyme
mix, 2 mM of each primer and 1 mM of TaqMan probe. The
cycling conditions were as follows: RT step 50 C for 10 min,
initial denaturation at 95 C for 5 min and 45 cycles at 95 C for
15 s and at 60 C for 60 s. The data was analyzed using software
SDS version 1.4.
2.3. Detection of IgM antibodies
DENV speciﬁc IgM antibodies were detected using DENV
IgM Capture ELISA (Panbio, Queensland, Australia) according
to the protocol provided by the manufacturer. Results were
interpreted by the calculation of cut-off and index values.
2.4. Statistical analysis
Statistical analysis of data was performed by chi-square test
and student t-test using SPSS version 18.0 (SPSS Inc., Chicago,
IL, USA). A P value of <0.05 was considered as signiﬁcant.
3. Results
A total of 323 serum samples were collected from suspected
dengue fever cases during the month of May–November 2013
(Table 1). Gender distribution was signiﬁcant (P = 0.006) with
65% male. Age was found to be a signiﬁcant characteristic
among dengue positive and dengue negative cases by indepen-
dent sample t-test (P = 0.025). Most effected 49.5% (160/323)
age group was 16–30 years old. Mean days after illness was
4.78 ± 2.06 for dengue positive cases which was found signif-
icant compared to dengue negative group (P = 0.001). Platelets
count and TLC values were signiﬁcantly different between
dengue positive and negative groups.
3.1. Month wise distribution of cases
During the study period from May–November 2013 the
highest number of dengue fever cases was reported in September
(Figure 1).
3.2. Symptoms correlation
The frequency of clinical symptoms was unequal in patients
with acute dengue infection compared to dengue negative cases.
Fever, body ache, retro-orbital pain, rash and bleeding were the
most common symptoms among dengue positive cases
(P > 0.05) (Table 2).
Figure 1. Month wise distribution of dengue fever cases in 2013 outbreak.
Table 2
Association of the most frequently reported symptoms presented by
dengue patients enrolled in the study (n = 323).
Symptoms Dengue positive
samples n (%)
Dengue negative
samples n (%)
P-
value
Fever 304 (94) 19 (6) –
Headache 58 (68) 27 (32) 0.428
Body ache 144 (82) 32 (18) 0.001
Diarrhea 3 (60) 2 (40) 0.388
Rash 4 (100) – 0.006
Vomiting 8 (80) 1 (20) 0.584
Retro-orbital
pain
27 (82) 6 (18) 0.030
Bleeding 4 (100) 0 0.016
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The non-structural antigen assay was positive in 65% (209
out of 323) of tested samples. The highest percentage of NS1
positive samples were collected on day 1–3 after onset with 80%
(57 out of 71) followed by 68% (115/170) on day 4–6, 48% (30
out of 63) on day 7–9 and 37% (7 out of 19) after day 9 of onset
of infection.
3.4. Viral RNA detection by real-time PCR
A total of 62% (201 out of 323) serum samples were found
positive by real-time PCR. The Ct values of positive cases varied
from 22 to 36. DENV-3 was the dominant serotype detected
from 34% (69 out of 201) patients followed by DENV-2 in 22%
(45 out of 201) patients and DENV-1 found in 12% (24 out of
201) subjects. DENV-4 was not found in any of the study
samples. Mixed infection with multiple dengue serotypes was
detected in 31% (63 out of 201) samples. The proportion of
positive samples in real-time PCR was the highest in samples
collected on day 1–3 with 69% (49 out of 71) followed by
59.4% (107 out of 170) on day 4–6 and 55% (35 out of 63) on
day 7–9 after onset and gradually decreased after day 9 of dis-
ease onset.
3.5. Detection of IgM antibodies
All 323 serum samples were tested for the detection of anti-
DENV IgM antibody by ELISA. Out of 323 samples, IgM an-
tibodies were detected in 59% (190/323) suspected cases. The
IgM antibodies were found in 35% (25 out of 71) of samples
collected on day 1–3 and increasing trend was found in samples
collected on day 4–6 with 60% (102 out of 170), 76% (48 out of
63) on day 7–9 and 79% (15 out of 19) in samples collected after
day 9 of symptoms onset.
3.6. Comparative results
The results of real-time PCR, NS1 antigen and IgM anti-
bodies were compared with reference to the time of sample
collection. IgM ELISA in combination with NS1 antigen ELISA
or real-time PCR were found suitable marker for the early
diagnosis of dengue infection. Using the combination of NS1
and IgM, 87% (283 out of 323) samples were positive. Positivity
of NS1 ELISA and real-time PCR was 84% (271 out of 323),
IgM ELISA and real-time PCR was 83% (268 out of 323). Only
6% (19 out of 323) samples were found negative on alldiagnostic parameters used during this study. The sensitivities of
real-time PCR and NS1 ELISA were almost similar and com-
bination of NS1 ELISA or real-time PCR with IgM ELISA
increased diagnostic sensitivity (Tables 3–5).
4. Discussion
In Pakistan, the ﬁrst outbreak of DENV was reported in 1982
in Punjab Province which was limited to district Lahore [15].
Since then, a number of outbreaks have been reported from
KPK, Sindh and Balochistan Province, but no proper attention
was given to establish a comprehensive laboratory based
surveillance program in order to understand the burden of
disease, and circulating viral serotypes, which may be helpful
for early implementation of disease surveillance and control.
As a consequence, in 2011 and 2013 two major DENV
outbreaks occurred in district Lahore (Punjab Province) and
Swat, Mansehra and adjacent areas of KPK Province [11].
These outbreaks were relatively of short duration but high
number of dengue fever cases and dengue related deaths were
reported possibly due to two main factors: presence of a large
immunologically susceptible/naive population and
unavailability of accurate assay for early diagnosis of dengue
fever which is important for the clinical management of
patient and helpful in preventing the development of DHF and
DSS [16].
Therefore in this study, the diagnostic accuracy for DENV
infection was assessed for various assays, with respect to the
date of onset of infection and sample collection. We analyzed of
323 serum samples collected from suspected dengue cases
during 2013 outbreak in two districts of KPK using three
different diagnostic tests: real-time PCR, NS1 ELISA and IgM
Table 3
Comparison of real-time PCR and NS1 ELISA.
NS1+ NS1−
Real-time PCR+ 143 58
Real-time PCR− 66 56
Total 209 114
Table 4
Comparison of real-time PCR and IgM ELISA.
IgM+ IgM−
Real-time PCR+ 118 83
Real-time PCR− 72 50
Total 190 133
Table 5
Comparison of IgM ELISA and NS1 ELISA.
NS1+ NS1−
IgM+ 120 70
IgM− 89 44
Total 209 114
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logical data from the cases were also analyzed. The principally
affected age group was 16–30 years old followed by 31–45 age
groups as previously reported [17]. Demographic data analysis
showed that the majority of the patients were male, with male
to female ratio of 2:1. An observation also reported in
previous studies from KPK Province [11,18]. The most
common symptoms observed in cases presented as dengue
fever and DHF was, fever (100%) followed by body ache
(54%) headache (26%) and retro-orbital pain (10%), an obser-
vation similar to other reports from South Asia [19,20]. The low
platelet count reported earlier was observed in few cases
[21,22]. Similarly we found 51% cases with leukocyte count
below 4000 cells/mL while other studies have reported
leucopenia in up to 90% cases with DENV infection [23].
Based on real-time PCR testing, we conﬁrmed the circulation
of three dengue serotypes (DENV-1, 2 and 3) in contrast to
Amjad Ali et al who reported the circulation of only two dengue
serotypes DENV-2 and 3 [18]. This may be attributed to the use
of highly sensitive real-time PCR in our study compared to
conventional RT-PCR used in previous studies. The highest
numbers of cases were detected in post monsoon period which
might be due to increased humidity/precipitation and heavy
rainfall which provide suitable environment for vector breeding.
This observation is consistent with reports of dengue outbreaks
in other provinces, as well as from different studies conducted in
India, Nepal and other South Asian Countries [17,24,25].
Comparison of serotype speciﬁc real-time PCR [14] and NS1
antigen ELISA showed almost similar results in early disease
period, thus the use of NS1 ELISA is arguably an appropriate
and reliable method for early diagnosis in laboratory setting
where the facility of real-time PCR is not available. However
for well equipped laboratories the use of real-time PCR is a
rapid, sensitive and suitable diagnostic test which cannot only
detect viral RNA but also specify the viral serotypes at the same
time [13]. The detection of DENV by serotype speciﬁc real-time
PCR is very important, because the co-infection with multipledengue serotypes and secondary dengue infection with different
serotypes can lead to DHF and DSS [26]. On the other hand, the
detection of IgM antibodies by serologic methods can give
excellent results in later stages (after day 5 of infection) when
high concentrations of immunoglobulin are detectable in blood.
The accurate and exact date of onset of DENV infection
needs to be taken into account before choosing which diagnostic
tool to be use.
Deﬁnitive diagnosis of dengue fever cannot be based on
clinical judgment alone as the disease presentation is indistin-
guishable from many febrile illnesses like malaria, measles,
rubella, chikungunya and other bacterial and rickettsial diseases.
In the presence of limited resources, this can lead to gross
mismatch between estimated and actual number of cases [27].
Therefore pro-active laboratory based support is absolutely
required in dengue surveillance, not only in diagnosis of sus-
pected cases of dengue fever and DHF but also in monitoring the
serotypes and strains circulating in the population and to provide
an early warning of impending dengue epidemics. At govern-
mental level, it should be important to introduce public aware-
ness programs to minimize the spread of outbreak in the country.
In addition the identiﬁcation of risk factors like vector breeding
sites and control strategies is another responsibility of the strong
and fully functional and highly optimized surveillance system
which is still lacking or under developmental process in
Pakistan.
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